S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
The Next Stage Of Google’s Rally Just Started
A 73-Year-Old Market Signal With 95% Accuracy Just Flashed (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
A 73-Year-Old Market Signal With 95% Accuracy Just Flashed (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
4 Proven Strategies to Help You Find Success in Executive Leadership
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
'Control, Surveillance and Manipulation': How TikTok's Office Surveillance Could Backfire and Cost The Company Billions
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
The Next Stage Of Google’s Rally Just Started
A 73-Year-Old Market Signal With 95% Accuracy Just Flashed (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
A 73-Year-Old Market Signal With 95% Accuracy Just Flashed (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
4 Proven Strategies to Help You Find Success in Executive Leadership
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
'Control, Surveillance and Manipulation': How TikTok's Office Surveillance Could Backfire and Cost The Company Billions
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
The Next Stage Of Google’s Rally Just Started
A 73-Year-Old Market Signal With 95% Accuracy Just Flashed (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
A 73-Year-Old Market Signal With 95% Accuracy Just Flashed (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
4 Proven Strategies to Help You Find Success in Executive Leadership
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
'Control, Surveillance and Manipulation': How TikTok's Office Surveillance Could Backfire and Cost The Company Billions
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
The Next Stage Of Google’s Rally Just Started
A 73-Year-Old Market Signal With 95% Accuracy Just Flashed (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
A 73-Year-Old Market Signal With 95% Accuracy Just Flashed (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
4 Proven Strategies to Help You Find Success in Executive Leadership
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
'Control, Surveillance and Manipulation': How TikTok's Office Surveillance Could Backfire and Cost The Company Billions
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
NASDAQ:KPTI

Karyopharm Therapeutics (KPTI) SEC Filings & 10K Form

$1.34
-0.03 (-2.19%)
(As of 09/29/2023 ET)
Compare
Today's Range
$1.32
▼
$1.44
50-Day Range
$1.14
▼
$1.81
52-Week Range
$1.11
▼
$6.01
Volume
858,751 shs
Average Volume
1.46 million shs
Market Capitalization
$153.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.67
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Recent Karyopharm Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
09/12/2023
3:07 PM		BOHLIN GAREN G (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
3:27 PM		Cheng Sohanya Roshan (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
3:29 PM		Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
7:06 AM		Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2023
7:17 AM		Karyopharm Therapeutics (Issuer)
Su Zhen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/01/2023
7:20 AM		Karyopharm Therapeutics (Issuer)
Su Zhen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2023
7:59 AM		Karyopharm Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/02/2023
6:48 AM		Karyopharm Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2023
6:37 AM		Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2023
4:37 PM		Karyopharm Therapeutics (Issuer)
Poulton Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2023
1:26 PM		Karyopharm Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
07/06/2023
4:36 PM		Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2023
11:15 PM		Karyopharm Therapeutics (Filer)
Form EFFECT
05/04/2023
6:53 AM		Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2023
7:04 AM		Karyopharm Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2023
5:09 PM		Karyopharm Therapeutics (Issuer)
Rangwala Reshma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2023
7:02 AM		Karyopharm Therapeutics (Filer)
Form DEF 14A
04/11/2023
7:11 AM		Karyopharm Therapeutics (Filer)
Form DEFA14A
04/11/2023
7:19 AM		Karyopharm Therapeutics (Filer)
Form ARS
03/02/2023
4:38 PM		Karyopharm Therapeutics (Issuer)
Poulton Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
4:39 PM		Karyopharm Therapeutics (Issuer)
Rangwala Reshma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
4:28 PM		Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
4:30 PM		Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
4:33 PM		Cheng Sohanya Roshan (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
4:35 PM		Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
4:36 PM		Karyopharm Therapeutics (Issuer)
Mitchener Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2023
7:52 AM		Karyopharm Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/17/2023
7:59 AM		Karyopharm Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/17/2023
6:34 AM		Karyopharm Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2023
6:53 AM		Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2023
2:41 PM		Chione Ltd (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G/A
02/14/2023
2:31 PM		Avidity Partners Management LP (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G/A
02/02/2023
11:38 AM		Karyopharm Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/20/2023
4:17 PM		BlackRock Inc. (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G
01/09/2023
7:06 AM		Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2023
5:16 PM		Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2023
11:15 PM		Karyopharm Therapeutics (Filer)
Form EFFECT
12/23/2022
3:14 PM		Karyopharm Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/08/2022
9:22 AM		Avidity Partners Management LP (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G
12/05/2022
7:41 AM		Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2022
5:19 PM		Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:KPTI) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -